Mosaic Raises Funds for Robotic Surgery

AI Summary

Mosaic Intelligence Labs has raised $47 million in two seed-funding rounds led by 8VC and Fundomo to develop a semi-autonomous catheter that navigates blood vessels during surgery. The article also reports that Anthropic has begun its IPO roadshow with a tentative valuation of $1.26 trillion to $1.4 trillion.

Anthropic said on Tuesday that it has launched its roadshow, a 7 to 10 day period ahead of an IPO in which a company pitches prospective institutional investors like mutual funds, pension funds and hedge funds. Interestingly, the tentative valuation the Claude-maker set, of between $1.26 trillion to $1.4 trillion, was slightly lower than what investors initially expected. (And, it’s also around the $1.25 trillion valuation that OpenAI recently raised $11 billion at, despite the fact that Anthropic generates more revenue. That’s likely for several reasons, including that Anthropic likely wants its stock to have some wiggle room to trade up after its IPO.) Meanwhile, the largest pure-play robotics company in the world by revenue and market cap is Intuitive Surgical, which makes the da Vinci Surgical System, a multi-armed contraption that human surgeons use on a remote-control basis to perform a variety of operations. But da Vinci was first unveiled over 25 years ago, and a new generation of robotics companies is aiming to further automate surgery by harnessing the latest advances in AI. One such startup, Mosaic Intelligence Labs, has raised $47 million across two rounds of seed funding led by 8VC and Fundomo, the one-year-old company told The Information exclusively.  Mosaic is developing a semi-autonomous catheter that can “find its own way” through a patient’s blood network during a surgery, said co-founder and CEO Ileana Pirozzi. As a human surgeon feeds the catheter into the body, the tip of the catheter will bend in different directions to travel down the correct veins and arteries.